Side by side
How the two compare across structure, mechanism studied, evidence and regulatory status, based on published research.
| Property | Oxytocin | Carbetocin |
|---|---|---|
| Class | Posterior pituitary hormone | Oxytocin analogue |
| Research category | obstetrics and lactation | obstetrics |
| Evidence level | High | High |
| Overall status | Approved (Rx) — labour induction and postpartum haemorrhage | Approved (EU national, Brazil); heat-stable formulation available |
| FDA | Approved (Rx) | Not approved |
| EMA | Approved (Rx) | Approved (Rx) — national authorisations |
| WADA | Check current list | Not listed |
| Mechanism studied | Oxytocin → Oxytocin receptor → Myometrial contraction → Uterine tone | Carbetocin → Oxytocin receptor → Sustained uterine contraction → Blood-loss endpoints |
| Molecular weight | 1,007.2 g/mol | 988.2 g/mol |
| Sizes in stock | Not currently listed | Not currently listed |
Where the research overlaps
Both compounds are studied within Endocrine research. Oxytocin is classed as posterior pituitary hormone, while Carbetocin is oxytocin analogue. Evidence is rated high for Oxytocin and high for Carbetocin.
FOR RESEARCH USE ONLY.Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.